Oral Erythritol Reduces Energy Intake during a Subsequent

cholecystokinin energy intake erythritol gastrointestinal satiation hormone healthy participants low-caloric sweeteners sucralose sucrose

Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
21 Sep 2022
Historique:
received: 08 09 2022
revised: 16 09 2022
accepted: 19 09 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

The impact of oral erythritol on subsequent energy intake is unknown. The aim was to assess the effect of oral erythritol compared to sucrose, sucralose, or tap water on energy intake during a subsequent ad libitum test meal and to examine the release of cholecystokinin (CCK) in response to these substances. In this randomized, crossover trial, 20 healthy volunteers received 50 g erythritol, 33.5 g sucrose, or 0.0558 g sucralose dissolved in tap water, or tap water as an oral preload in four different sessions. Fifteen minutes later, a test meal was served and energy intake was assessed. At set time points, blood samples were collected to quantify CCK concentrations. The energy intake (ad libitum test meal) was significantly lower after erythritol compared to sucrose, sucralose, or tap water (p < 0.05). Before the start of the ad libitum test meal, erythritol led to a significant increase in CCK compared to sucrose, sucralose, or tap water (p < 0.001). Oral erythritol given alone induced the release of CCK before the start of the ad libitum test meal and reduced subsequent energy intake compared to sucrose, sucralose, or tap water. These properties make erythritol a useful sugar alternative.

Identifiants

pubmed: 36235571
pii: nu14193918
doi: 10.3390/nu14193918
pmc: PMC9571225
pii:
doi:

Substances chimiques

Water 059QF0KO0R
Sucrose 57-50-1
Cholecystokinin 9011-97-6
Erythritol RA96B954X6

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Swiss National Science Foundation
ID : 320030E_189329
Pays : Switzerland

Références

Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15075-80
pubmed: 17724332
Diabetes Care. 2013 Dec;36(12):e202-3
pubmed: 24265374
Am J Clin Nutr. 2017 Aug;106(2):614-622
pubmed: 28659294
Diabetes Obes Metab. 2022 Feb;24(2):268-280
pubmed: 34658116
Nutr Res. 2011 Dec;31(12):882-8
pubmed: 22153513
Adv Nutr. 2021 Jul 30;12(4):1481-1499
pubmed: 33439973
Nat Rev Endocrinol. 2022 Apr;18(4):205-218
pubmed: 35064240
Obes Rev. 2010 Mar;11(3):251-70
pubmed: 20122136
Br J Nutr. 2022 Feb 14;:1-25
pubmed: 35152916
Appetite. 2016 Dec 1;107:596-603
pubmed: 27620647
Diabetes. 2015 Feb;64(2):370-82
pubmed: 25157092
J Physiol. 2007 Jul 1;582(Pt 1):379-92
pubmed: 17495045
J Clin Invest. 2015 Mar 2;125(3):908-17
pubmed: 25664852
Diabetes. 2012 Jan;61(1):187-96
pubmed: 22124465
Appetite. 2016 Dec 1;107:398-405
pubmed: 27567550
Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G735-9
pubmed: 19221011
JAMA Netw Open. 2021 Sep 1;4(9):e2126313
pubmed: 34581796
Br J Sports Med. 2016 Apr;50(8):496-504
pubmed: 27044603
J Clin Endocrinol Metab. 2021 Mar 8;106(3):654-664
pubmed: 33300990
Nutrients. 2019 Nov 09;11(11):
pubmed: 31717525
Microbiome. 2021 Jan 12;9(1):11
pubmed: 33431052
Eur J Clin Nutr. 1994 Apr;48(4):286-92
pubmed: 8039489
Clin Chem. 1998 May;44(5):991-1001
pubmed: 9590372
Br J Nutr. 2011 May;105(9):1320-8
pubmed: 21255472
J Nutr. 2022 May 5;152(5):1228-1238
pubmed: 35135006
Am J Physiol Endocrinol Metab. 2016 Jun 1;310(11):E1053-61
pubmed: 27117004
Neuroimage. 2008 Feb 15;39(4):1559-69
pubmed: 18096409
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
J Clin Invest. 2015 Feb;125(2):782-6
pubmed: 25555217
Diabetes Obes Metab. 2021 Jun;23(6):1311-1321
pubmed: 33565706
Regul Toxicol Pharmacol. 1996 Oct;24(2 Pt 2):S191-7
pubmed: 8933633
J Clin Endocrinol Metab. 2012 Aug;97(8):2597-605
pubmed: 22679063
Am J Physiol Endocrinol Metab. 2011 Aug;301(2):E317-25
pubmed: 21540445
Diabetes Res Clin Pract. 2019 Sep;155:107786
pubmed: 31326455
Science. 2018 Sep 21;361(6408):
pubmed: 30237325
Am J Clin Nutr. 2018 Sep 1;108(3):485-491
pubmed: 30535090
Appl Physiol Nutr Metab. 2020 Jun;45(6):606-612
pubmed: 31697573
Nutrients. 2021 Nov 05;13(11):
pubmed: 34836205
J Clin Endocrinol Metab. 2010 Jan;95(1):215-21
pubmed: 19892837
Am J Physiol. 1997 Nov;273(5):E981-8
pubmed: 9374685
Int J Obes Relat Metab Disord. 2000 Jan;24(1):38-48
pubmed: 10702749
Physiol Rev. 2017 Jan;97(1):411-463
pubmed: 28003328
Front Nutr. 2021 Jan 07;7:598340
pubmed: 33490098
Nat Neurosci. 2022 Feb;25(2):191-200
pubmed: 35027761
J Food Sci. 2020 Mar;85(3):771-780
pubmed: 32043600
Diabetes. 2017 Aug;66(8):2144-2149
pubmed: 28385801
Curr Atheroscler Rep. 2019 Nov 19;21(12):49
pubmed: 31741078
Nutr Diabetes. 2019 Nov 14;9(1):35
pubmed: 31727876
Cell Metab. 2020 Mar 3;31(3):493-502.e7
pubmed: 32130881
Nutrients. 2017 Feb 14;9(2):
pubmed: 28216550
J Physiol. 1968 Feb;194(2):317-26
pubmed: 5639356
World Rev Nutr Diet. 1999;85:110-6
pubmed: 10647341
Physiol Behav. 1988;44(4-5):645-9
pubmed: 3237850

Auteurs

Fabienne Teysseire (F)

St. Clara Research Ltd. at St. Claraspital, 4002 Basel, Switzerland.
Faculty of Medicine, University of Basel, 4001 Basel, Switzerland.

Emilie Flad (E)

St. Clara Research Ltd. at St. Claraspital, 4002 Basel, Switzerland.
Faculty of Medicine, University of Basel, 4001 Basel, Switzerland.

Valentine Bordier (V)

St. Clara Research Ltd. at St. Claraspital, 4002 Basel, Switzerland.
Faculty of Medicine, University of Basel, 4001 Basel, Switzerland.

Aleksandra Budzinska (A)

Translational Research Center for Gastrointestinal Disorders, Laboratory for Brain-Gut Axis Studies, Department of Chronic Diseases and Metabolism, Catholic University of Leuven, 3000 Leuven, Belgium.
Leuven Brain Institute, Catholic University of Leuven, 3000 Leuven, Belgium.

Nathalie Weltens (N)

Translational Research Center for Gastrointestinal Disorders, Laboratory for Brain-Gut Axis Studies, Department of Chronic Diseases and Metabolism, Catholic University of Leuven, 3000 Leuven, Belgium.
Leuven Brain Institute, Catholic University of Leuven, 3000 Leuven, Belgium.

Jens F Rehfeld (JF)

Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, 1172 Copenhagen, Denmark.

Christoph Beglinger (C)

St. Clara Research Ltd. at St. Claraspital, 4002 Basel, Switzerland.

Lukas Van Oudenhove (L)

Translational Research Center for Gastrointestinal Disorders, Laboratory for Brain-Gut Axis Studies, Department of Chronic Diseases and Metabolism, Catholic University of Leuven, 3000 Leuven, Belgium.
Leuven Brain Institute, Catholic University of Leuven, 3000 Leuven, Belgium.
Cognitive and Affective Neuroscience Lab, Department of Psychological and Brain Sciences, Dartmouth College, Hanover, NH 03755, USA.

Bettina K Wölnerhanssen (BK)

St. Clara Research Ltd. at St. Claraspital, 4002 Basel, Switzerland.
Faculty of Medicine, University of Basel, 4001 Basel, Switzerland.

Anne Christin Meyer-Gerspach (AC)

St. Clara Research Ltd. at St. Claraspital, 4002 Basel, Switzerland.
Faculty of Medicine, University of Basel, 4001 Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH